The randomized controlled trial of the R-THP-COP therapy (14 days) versus R-CHOP therapy (14 days) for treatment of patients under the age of 70 with untreated advanced stage diffuse large B-cell lymphoma, Phase II and III study - The randomized controlled trial of the R-THP-COP therapy (14 days) versus R-CHOP therapy (14 days) for treatment of patients under the age of 70 with untreated advanced stage diffuse large B-cell lymphoma, Phase II and III study

Gifu University Hospital0 个研究点目标入组 80 人开始时间: 2012年2月13日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with HIV or HTLV-1. 2)Patients with uncontrolled intercurrent illness including, but not limited to, malignant hypertension, congestive heart failure, coronary insufficiency, a new onset of myocardial infarction within 3 months , liver cirrhosis, uncontrolled hyperglycemia, renal failure, pulmonary fibrosis, or bleeding tendency. 3)Patients with another active malignancy 4)Patients who are pregnant or lactating, or have an intention to get pregnant 5)Patients with severe mental disease. 6)Patients who have had chemotherapy or radiotherapy prior to entering the study. 7)Patients who are judged inappropriate for the entry into the study by the principle doctor.

发起方

Gifu University Hospital